INSIGHTS & ANNOUNCEMENTS

Where capital, technology, and the region’s priorities meet

A selective perspective on the trends, relationships, and developments shaping Saudi Arabia, the Gulf region, and the global organizations engaging with them.

SELAX SELAX

The Next Geography of Biotechnology

The GCC, North Africa and Turkey have a growing role in biotechnology. Gulf investors are backing US drug developers, pharmaceutical acquisitions are connecting businesses across the region, and universities are building relationships with international discovery teams.

For US companies, these partnerships can contribute to a stronger global business. For regional investors and institutions, they offer a stake in the medicines developed and an opportunity to build scientific and commercial capabilities at home. Most importantly, they can help bring new medicines to patients.

Our latest SELAX perspective looks at the financial case for these partnerships, with examples including Biohaven’s memorandum of understanding with KAUST on next-generation degrader discovery.

Read More